Navigation Links
Jazz Pharmaceuticals Receives FDA Complete Response Letter Regarding JZP-6 for Treatment of Fibromyalgia
Date:10/11/2010

cals' website at www.jazzpharmaceuticals.com.

About Jazz Pharmaceuticals, Inc.

Jazz Pharmaceuticals (Nasdaq: JAZZ) is a specialty pharmaceutical company that identifies, develops and commercializes innovative treatments for important, underserved markets in neurology and psychiatry. For further information see www.jazzpharmaceuticals.com.

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995

This press release contains forward-looking statements, including but not limited to statements related to Jazz Pharmaceuticals' JZP-6 (sodium oxybate) product candidate, including statements related to Jazz Pharmaceuticals' plans to meet with the FDA, the outcome of any such meeting and all future regulatory matters, including its future approval and the future development of JZP-6.  These forward-looking statements are based on the company's current expectations and inherently involve significant risks and uncertainties.  Jazz Pharmaceuticals' actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, risks related to the uncertain and time-consuming regulatory approval process for JZP6, risks related to potential further development of JZP-6, and other risks detailed from time-to-time under the caption "Risk Factors" and elsewhere in Jazz Pharmaceuticals' Securities and Exchange Commission filings and reports, including in its Quarterly Report on Form 10-Q for the quarter ended June 30, 2010 filed by Jazz Pharmaceuticals with the Securities and Exchange Commission on August, 11, 2010. Jazz Pharmaceuticals undertakes no duty or obligation to update any forward-looking statement
'/>"/>

SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Announces Initiation of XIAFLEX® Phase III Studies for Peyronies Disease
2. Valeant Pharmaceuticals Announces That Alexza Pharmaceuticals Has Received a Complete Response Letter for AZ-004 (Staccato® Loxapine) Inhalation Aerosol NDA
3. Alexza Pharmaceuticals Receives Complete Response Letter for AZ-004 (Staccato® Loxapine) NDA
4. Bexion Pharmaceuticals Continues to Gain Support from National Cancer Institute (NCI)
5. Onyx Pharmaceuticals Provides Status Update on Carfilzomib
6. Onyx Pharmaceuticals Announces Teleconference to Provide Status Update on Carfilzomib
7. Star Scientific Comments on Roskamp Institutes Plans to Conduct Human Alzheimers Clinical Trials Using a Compound (RCP-006) Developed by Rock Creek Pharmaceuticals, Inc.
8. VentiRx Pharmaceuticals Reports Positive Clinical Data for VTX-1463 in Allergic Rhinitis
9. Regeneron Pharmaceuticals, Inc. Announces The Sale of 4,500,000 Shares of Common Stock
10. Lotus Pharmaceuticals Retains Sichenzia Ross Friedman Ference LLP as General Legal Counsel
11. ISTA Pharmaceuticals Reports Positive Preliminary Results from its Phase 1/2 Clinical Study of Bepotastine Besilate Nasal Spray for the Treatment of Symptoms Associated with Seasonal Allergic Rhinitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)...   Easy Breathe , the fastest growing online sleep ... " - has received more than 4.5 million unique page views ... thrilled that so many people are finding our blog and reading ... "We,re committed to making sleep apnea more widely known and hope ... sleep apnea news , troubleshooting advice , and ...
(Date:8/20/2014)... NEW YORK, Aug 20, 2014 Reportlinker.com ... available in its catalogue: Global Patient ... This report analyzes the worldwide markets ... following Product Segments: Floor Scales, Infant & Baby ... report provides separate comprehensive analytics for the US, ...
(Date:8/20/2014)... 20, 2014  Quantum Materials Corporation (OTCQB:QTMM) today ... patent families from Bayer Technology Services GmbH, the global ... AG of Leverkusen, Germany . ... intellectual property protection for advances Quantum Materials ... (QD) manufacturing. In addition, the Bayer patents cover ...
Breaking Medicine Technology:Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 2Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 3Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 4Global Patient Scales Industry 2Global Patient Scales Industry 3Global Patient Scales Industry 4Global Patient Scales Industry 5Global Patient Scales Industry 6Global Patient Scales Industry 7Global Patient Scales Industry 8Global Patient Scales Industry 9Global Patient Scales Industry 10Global Patient Scales Industry 11Global Patient Scales Industry 12Global Patient Scales Industry 13Global Patient Scales Industry 14Global Patient Scales Industry 15Global Patient Scales Industry 16Global Patient Scales Industry 17Global Patient Scales Industry 18Global Patient Scales Industry 19Quantum Materials Acquires Bayer Technology Services Quantum Dot Manufacturing and Quantum Dot Solar Cell Patents 2Quantum Materials Acquires Bayer Technology Services Quantum Dot Manufacturing and Quantum Dot Solar Cell Patents 3Quantum Materials Acquires Bayer Technology Services Quantum Dot Manufacturing and Quantum Dot Solar Cell Patents 4
... /PRNewswire/ -- Treatment of,coronary artery disease (CAD) appears to ... study published today in The,American Journal of Cardiology. , ... 10.6 percent from 2002 to 2005, possibly due,to broader ... as well as declines in risk factors like smoking. ...
... Research from Non-clinical Studies Presented at the ... Symposia Molecular,Targets for Cancer Meetings Support Phase ... March 20, 2007,/PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, Inc. ... SNS-314, at,two leading scientific meetings focused on ...
Cached Medicine Technology:Hospitalization Rates for Coronary Artery Disease Decline in the,U.S. 2Hospitalization Rates for Coronary Artery Disease Decline in the,U.S. 3Sunesis Pharmaceuticals Presents SNS-314 Aurora Kinase Inhibitor,Data Showing Broad Anti-Tumor Activity, Dosing Flexibility 2Sunesis Pharmaceuticals Presents SNS-314 Aurora Kinase Inhibitor,Data Showing Broad Anti-Tumor Activity, Dosing Flexibility 3
(Date:8/21/2014)... Centre, NY (PRWEB) August 21, 2014 ... law firm with over 25 years of experience advocating ... prescription drugs and defective medical devices, announces the launch ... information to those women who believe they have been ... site offers valuable information about the severe adverse side ...
(Date:8/21/2014)... Beach, FL (PRWEB) August 21, 2014 The ... disturbing trend in Boynton Beach, FL. For many years, countless ... make a difference in the community a new helpline was ... and teens in Florida who are seeking to overcome their ... the Troubled Teens Boynton Beach helpline at (561) 257-4053, parents ...
(Date:8/21/2014)... Albuquerque, NM (PRWEB) August 21, 2014 ... created by the Centers for Disease Control and ... facilities in assessing their compliance with the immunization ... policies and the CDC's General Recommendations on Immunizations. ... one of the many procedures in place to ...
(Date:8/21/2014)... 2014 Recently nominated as the Women’s Radio ... journey to be the man he is today. Growing up, ... a positive look on women, respecting them as professionals and individuals. ... and thanks to a man who he had the pleasure of ... , KC Armstrong’s name will ring a bell to most of ...
(Date:8/21/2014)... Today, Fecbek.com, a leading wedding dresses ... of wedding dresses. And all these elegant, gorgeous and ... excellent designers. , A wedding dress or wedding gown ... wedding ceremony. Color, style and ceremonial importance of the ... the wedding participants. In order to satisfy every customer, ...
Breaking Medicine News(10 mins):Health News:Rottenstein Law Group LLP Announces Launch of WeHelpWomen.com 2Health News:Troubled Teens in Boynton Beach, FL Turn to Helpline for Valuable Assistance 2Health News:ACC Health Raises the Bar Again by Completing the CQIIP Certification Program 2Health News:WRNW1's KC Armstrong Expresses Thanks and Appreciation to Howard Stern 2Health News:Elegant Wedding Dresses Are for Sale at Fecbek.com 2
... release is also available in Spanish . ... Medicine at the University of Granada , consisted ... accident and emergency departments in Spanish hospitals. The researchers concluded ... to create an immigrant treatment working party, establish a direct ...
... Forefront of e-prescribing with Millions of Transactions, ... Software today joins an,esteemed list of petitioners ... W.,Bush to revise regulations which prohibit controlled ... letter from the e-Prescribing,Controlled Substances Coalition, such ...
... Aflac Incorporated,(NYSE: AFL ) announced today that ... Financial Services CEO Conference. President and Chief,Financial Officer Kriss ... to make a presentation on December 11 at 9:00 ... the,company,s outlook for the remainder of 2007 and its ...
... Inc. announced the following appointments by its subsidiary,Selective ... Lanza (Sparta, NJ), to executive vice president and ... senior vice president and,general counsel. Previously a corporate ... president and corporate secretary of QuadraMed,Corporation. Prior to ...
... Cancer Society study finds breast cancer patients who lack insurance, ... African American, or who are older are less likely to ... The study finds those groups are ten percent to three ... the breast cancer has spread to axillary (underarm) lymph nodes. ...
... account for a third of drug-related ER trips, study says ... just three drugs are responsible for a full third of ... adverse reactions to medications, a new study found. , In ... insulin and the heart drug digoxin caused about 58,000 emergency ...
Cached Medicine News:Health News:Emergency departments should offer immigrants translation, according to a study 2Health News:Sage Software Joins e-Prescribing Coalition for Presidential Petition 2Health News:Sage Software Joins e-Prescribing Coalition for Presidential Petition 3Health News:Aflac Incorporated to Present at the Goldman Sachs Financial Services CEO Conference 2007 2Health News:Selective Insurance Group Announces Officer Appointments 2Health News:Uninsured, others less likely to receive breast cancer test 2Health News:3 Common Drugs Trigger Most ER Visits by Seniors 2
... Cycling The Tetrad 2 thermal cycler ... MJ Research Tetrad chassis. As before, the ... the power supply is internal, while a large, ... Better yet, updated automatic lids -- Moto Alphas ...
PTC-100 thermal cycler, holds sixteen 25x75mm microscope slides & 24x0.2ml tubes...
... PCR Sprint with 24-well x 0.2ml sub-ambient ... (includes tube thermistor) Heating rates: up to ... from 4-99C; Excellent uniformity: better than 0.5C ... to use programming: directory program storage of ...
... what a thermal cycler can do for ... an easy graphic interface, and best of ... The iCycler thermal cycler will raise your ... do for you.,, iCycler Thermal Cycler Features:, ...
Medicine Products: